Journal article
A phase II trial of oblimersen sodium (G3139) in combination with doxorubicin (DOX) in advanced hepatocellular carcinoma (HCC). NCI protocol # 5798
Abstract
14072
Authors
Knox JJ; Chen E; Feld R; Nematollahi M; Pond GR; Cheiken R; Gill S; Zwiebel J; Moore M
Journal
Journal of Clinical Oncology, Vol. 24, No. 18_suppl, pp. 14072–14072
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 20, 2006
DOI
10.1200/jco.2006.24.18_suppl.14072
ISSN
0732-183X